HOME >> BIOLOGY >> NEWS
St. Jude/Mayo Clinic study finds direct link between CBP gene and lymphoma

(MEMPHIS, TENN.--Feb. 24, 2004) Inactivation of the gene CBP in certain immature white blood cells of mice causes lymphoma, a type of cancer also found in humans. The cancer is accompanied by changes in the expression of specific genes associated with development of the disease. These findings, from researchers at St. Jude Children's Research Hospital and the Mayo Clinic, are published in the Feb. 24 issue of Cancer Cell.

The key to the success of this work is the so-called "conditional knockout mouse" developed by the joint St. Jude-Mayo team, according to Paul Brindle, Ph.D., associate member in the St. Jude Department of Biochemistry. In a conditional knockout mouse, a specific gene is rendered inactive in only one type of cell, even though the gene exists in all normal cells of the body.

Brindle is co-author of the Cancer Cell article. The paper's senior author is Jan M. van Deursen, associate professor of Biochemistry and Molecular Biology and associate professor of Pediatrics at Mayo Clinic College of Medicine.

The research suggests that these CPB knockout mice will be a valuable tool in the further study of the role of CBP in the development of lymphomas. In the future, the mouse model might be useful for preclinical testing of novel drugs to treat these cancers.

"One finding that was particularly surprising was the specific effect the loss of CBP had on the mice," Brindle said. "It is commonly believed that CBP is intimately involved in the control of many genes. Yet the absence of CBP appears to promote lymphoma by cooperating with a narrow set of dysregulated genes." Lymphomas are cancers of either B-lymphocytes, which produce antibodies, or T-lymphocytes, a group of cells that either stimulate B cells or orchestrate attacks on cancer cells or invading organisms. In this study, loss of CBP only led to T-cell lymphoma.

Another unexpected finding was the lack of association between the loss of CBP function and a gene called p53
'"/>

Contact: Bonnie Cameron
bonnie.cameron@stjude.org
901-495-4815
St. Jude Children's Research Hospital
24-Feb-2004


Page: 1 2

Related biology news :

1. Creation of the UK Clinical Research Collaboration will boost clinical trials in UK
2. Hope Clinic of Emory Vaccine Center receives CDC contract
3. Clinical judgement still counts strongly alongside genetic testing
4. Jay Levy honored with 2004 Abbott Laboratories Award in Clinical and Diagnostic Immunology
5. Melvin Weinstein wins 2004 BD Award for Research in Clinical Microbiology
6. DFG to establish seven new Clinical Research Units
7. Clinical trial patients dont care about study sponsors or physician conflicts of interest
8. NIH establishes Rare Diseases Clinical Research Network
9. Grant strengthens research arm of Penn State Hershey Medical Centers ALS Clinic
10. Clinical study reports findings of combination therapy with DOXIL
11. Clinical study results published in NEJM show promising data on Antegren (natalizumab)

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/1/2019)... ... July 31, 2019 , ... ... the launch of the next generation of its FLIPR® Penta High-Throughput Cellular Screening ... industry-leading FLIPR® platform for monitoring of G-protein-coupled receptors (GPCRs) and ion channels, offering ...
(Date:7/24/2019)... ... July 24, 2019 , ... NDA ... a quality assurance expert with more than 20 years of experience working in ... has joined the firm as an Expert Consultant. , Dr. Hartzfeld has experience ...
(Date:7/19/2019)... ... July 18, 2019 , ... VetStem Biopharma has long been a ... As a result of a two-year research collaboration with Calidi Biotherapeutics, VetStem has signed ... veterinary medicine. VetStem should be able to fast-track this cancer therapy for use ...
Breaking Biology News(10 mins):
(Date:7/26/2019)... ... 25, 2019 , ... LeadingBiotech , an exclusive event ... its Boston BD conference to be held on September 10, 2019, ... , the event provides an opportunity for attendees to leverage insight from real-life ...
(Date:7/19/2019)... ... July 18, 2019 , ... Global precision motion and piezo ... piezo motion facilities in Lederhose, Germany, increasing their current footprint by half again. ... production in addition to general office space, a significant increase to its existing ...
(Date:7/17/2019)... COLLEGE PARK, Md. (PRWEB) , ... July 15, 2019 , ... ... cut DNA so that a certain trait can be removed, replaced, or edited, but ... Maryland, is looking far beyond these traditional applications in his latest publication in Nature ...
(Date:7/17/2019)... ... July 16, 2019 , ... Quidel ... report from Kalorama Information. Abbott, Roche and Siemens Healthineers and Response Biomedical also ... report, Worldwide Market for Point-of-Care (POC) Diagnostics . , Quidel is a ...
Breaking Biology Technology:
Cached News: